• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型氟喹诺酮衍生物的合成及体外抗菌活性评价。

Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives.

机构信息

Department of Industrial Chemistry, Alagappa University, Karaikudi-630 003, Tamil Nadu, India.

出版信息

Eur J Med Chem. 2010 Dec;45(12):6101-5. doi: 10.1016/j.ejmech.2010.09.036. Epub 2010 Sep 22.

DOI:10.1016/j.ejmech.2010.09.036
PMID:20933306
Abstract

A series of 1-ethyl-6,8-difluoro-4-oxo-7(4-aryl piperazin-1-yl) 1,4-dihydro-quinoline-3-carboxylic acid derivatives (6a-f) and 1-ethyl-6,8-difluoro-4-oxo-7(4-piperidin-1-yl) 1,4-dihydro-quinoline-3-carboxylic acid derivatives (7a-e) were synthesized and evaluated for antibacterial and antifungal activities. The antimicrobial activities of the compounds were assessed by the microbroth dilution technique. The compounds were also evaluated for antifungal activity against Candida albicans (ATCC 90028) and Cryptococcous neoformans (ATCC 14116) pathogens. The preliminary in vitro evaluation studies revealed that some of the compounds have promising antimicrobial activities.

摘要

一系列 1-乙基-6,8-二氟-4-氧代-7(4-芳基哌嗪-1-基)-1,4-二氢喹啉-3-羧酸衍生物(6a-f)和 1-乙基-6,8-二氟-4-氧代-7(4-哌啶-1-基)-1,4-二氢喹啉-3-羧酸衍生物(7a-e)被合成并评估了其抗菌和抗真菌活性。采用微量肉汤稀释法评估化合物的抗菌活性。还评估了化合物对白色念珠菌(ATCC 90028)和新型隐球菌(ATCC 14116)病原体的抗真菌活性。初步的体外评价研究表明,一些化合物具有有前景的抗菌活性。

相似文献

1
Synthesis and in vitro antimicrobial evaluation of novel fluoroquinolone derivatives.新型氟喹诺酮衍生物的合成及体外抗菌活性评价。
Eur J Med Chem. 2010 Dec;45(12):6101-5. doi: 10.1016/j.ejmech.2010.09.036. Epub 2010 Sep 22.
2
[Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].7-{4-[2-[2-取代-4-((5S)-5-乙酰氨基甲基-2-氧代-恶唑烷-3-基)]-苯基]-乙基}-哌嗪-1-基}-氟喹诺酮类的合成与抗菌活性
Yao Xue Xue Bao. 2006 Oct;41(10):990-9.
3
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.(1,4)-萘醌并-[3,2-c]-1H-吡唑及其(1,4)-萘氢醌衍生物作为抗真菌、抗菌和抗癌剂的合成。
Bioorg Med Chem Lett. 2005 Jul 1;15(13):3288-91. doi: 10.1016/j.bmcl.2005.04.066.
4
Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: synthesis and preliminary evaluation as antimicrobial agents.2-芳基喹啉-4-羧酸酰肼腙类化合物:作为抗菌剂的合成及初步评价
Bioorg Med Chem. 2006 Dec 15;14(24):8675-82. doi: 10.1016/j.bmc.2006.08.022. Epub 2006 Sep 1.
5
Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.O-烷基化和甲酰化酰基间苯三酚的抗寄生虫和抗菌活性。
Bioorg Med Chem. 2007 Jan 1;15(1):87-96. doi: 10.1016/j.bmc.2006.10.006. Epub 2006 Oct 10.
6
Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives.一些新型噻唑基噻唑烷-2,4-二酮衍生物的合成与抗菌活性
Bioorg Med Chem. 2007 Sep 15;15(18):6012-7. doi: 10.1016/j.bmc.2007.06.049. Epub 2007 Jun 29.
7
Design, synthesis and in vitro antibacterial/antifungal evaluation of novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)quinoline-3-carboxylic acid derivatives.新型 1-乙基-6-氟-1,4-二氢-4-氧代-7-(1-哌嗪基)喹啉-3-羧酸衍生物的设计、合成及体外抗菌/抗真菌活性评价。
Eur J Med Chem. 2009 Nov;44(11):4726-33. doi: 10.1016/j.ejmech.2009.05.028. Epub 2009 Jun 6.
8
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.新型(L)-α-氨基酸甲酯、杂烷基和芳基取代的1,4-萘醌衍生物作为抗真菌和抗菌剂的合成及生物学评价
Bioorg Med Chem Lett. 2005 Dec 1;15(23):5324-8. doi: 10.1016/j.bmcl.2005.08.032. Epub 2005 Oct 3.
9
Antifungal activity of artemisinin derivatives.青蒿素衍生物的抗真菌活性。
J Nat Prod. 2005 Aug;68(8):1274-6. doi: 10.1021/np050074u.
10
Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles.1-(苯并呋喃-2-基)-4-硝基-3-芳基丁-1-酮和3-(苯并呋喃-2-基)-4,5-二氢-5-芳基-1-[4-(芳基)-1,3-噻唑-2-基]-1H-吡唑的合成与抗菌活性评价
Eur J Med Chem. 2009 Jun;44(6):2632-5. doi: 10.1016/j.ejmech.2008.09.029. Epub 2008 Oct 2.

引用本文的文献

1
Exploration of Specific Fluoroquinolone Interaction with SARS-CoV-2 Main Protease (Mpro) to Battle COVID-19: DFT, Molecular Docking, ADME and Cardiotoxicity Studies.探索氟喹诺酮类药物与 SARS-CoV-2 主蛋白酶(Mpro)的特异性相互作用以对抗 COVID-19:DFT、分子对接、ADME 和心脏毒性研究。
Molecules. 2024 Oct 5;29(19):4721. doi: 10.3390/molecules29194721.
2
Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?氟喹诺酮类抗菌药物的副作用概述:新药与旧药对比,安全性方面是否有所进步?
Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804.
3
Novel heterocyclic 1,3,4-oxadiazole derivatives of fluoroquinolones as a potent antibacterial agent: Synthesis and computational molecular modeling.
新型杂环 1,3,4-噁二唑类氟喹诺酮类衍生物作为一种有效的抗菌剂:合成与计算分子模拟。
Mol Divers. 2022 Jun;26(3):1581-1596. doi: 10.1007/s11030-021-10287-3. Epub 2021 Aug 2.
4
Phytochemistry, Bioactivities, Pharmacokinetics and Toxicity Prediction of with Its Anticancer Potential against Human Lung, Breast and Colorectal Carcinoma Cell Lines.植物化学、生物活性、药代动力学和毒性预测及其对人肺癌、乳腺癌和结直肠癌细胞系的抗癌潜力。
Molecules. 2021 Feb 2;26(3):768. doi: 10.3390/molecules26030768.
5
Effect of Extract on Biofilm Formation, Adhesion With Its Antibacterial Activities Against Foodborne Pathogens, and Characterization of Bioactive Metabolites: An Approach.提取物对生物膜形成、与食源性病原体的粘附及其抗菌活性的影响以及生物活性代谢产物的表征:一种方法。
Front Microbiol. 2020 May 13;11:823. doi: 10.3389/fmicb.2020.00823. eCollection 2020.
6
Resistance to Antimicrobial Peptides in Vibrios.弧菌对抗微生物肽的耐药性。
Antibiotics (Basel). 2014 Oct 27;3(4):540-63. doi: 10.3390/antibiotics3040540.
7
Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones.新型3-苯基-1-[(4-芳基哌嗪-1-基)烷基]-哌啶-2,6-二酮的合成与生物学评价
Sci Pharm. 2011 Apr-Jun;79(2):225-38. doi: 10.3797/scipharm.1012-17. Epub 2011 Feb 12.